Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 775

1.

Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

Pilch B, Allemand E, Facompré M, Bailly C, Riou JF, Soret J, Tazi J.

Cancer Res. 2001 Sep 15;61(18):6876-84.

2.
3.

Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.

Soret J, Gabut M, Dupon C, Kohlhagen G, Stévenin J, Pommier Y, Tazi J.

Cancer Res. 2003 Dec 1;63(23):8203-11.

5.

Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Hanamura A, Cáceres JF, Mayeda A, Franza BR Jr, Krainer AR.

RNA. 1998 Apr;4(4):430-44.

6.

Selective inhibition of topoisomerase I and various steps of spliceosome assembly by diospyrin derivatives.

Tazi J, Bakkour N, Soret J, Zekri L, Hazra B, Laine W, Baldeyrou B, Lansiaux A, Bailly C.

Mol Pharmacol. 2005 Apr;67(4):1186-94. Epub 2004 Dec 29.

8.

PSKH1, a novel splice factor compartment-associated serine kinase.

Brede G, Solheim J, Prydz H.

Nucleic Acids Res. 2002 Dec 1;30(23):5301-9.

9.
10.

The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Petersen-Mahrt SK, Estmer C, Ohrmalm C, Matthews DA, Russell WC, Akusjärvi G.

EMBO J. 1999 Feb 15;18(4):1014-24.

11.

Phosphorylation regulates in vivo interaction and molecular targeting of serine/arginine-rich pre-mRNA splicing factors.

Yeakley JM, Tronchère H, Olesen J, Dyck JA, Wang HY, Fu XD.

J Cell Biol. 1999 May 3;145(3):447-55.

12.

Pre-mRNA splicing in plants: characterization of Ser/Arg splicing factors.

Lopato S, Mayeda A, Krainer AR, Barta A.

Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3074-9.

13.
15.

cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF.

Okamoto Y, Onogi H, Honda R, Yasuda H, Wakabayashi T, Nimura Y, Hagiwara M.

Biochem Biophys Res Commun. 1998 Aug 28;249(3):872-8.

PMID:
9731229
16.
17.
19.

A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.

Komatani H, Morita M, Sakaizumi N, Fukasawa K, Yoshida E, Okura A, Yoshinari T, Nishimura S.

Cancer Res. 1999 Jun 1;59(11):2701-8.

20.
Items per page

Supplemental Content

Write to the Help Desk